Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Forecasting the global burden of Alzheimer's disease.

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM.

Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.

PMID:
19595937
2.

Job demands and dementia risk among male twin pairs.

Potter GG, Helms MJ, Burke JR, Steffens DC, Plassman BL.

Alzheimers Dement. 2007 Jul;3(3):192-9. doi: 10.1016/j.jalz.2007.04.377.

3.

Prevalence of dementia in the United States: the aging, demographics, and memory study.

Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB.

Neuroepidemiology. 2007;29(1-2):125-32. Epub 2007 Oct 29.

4.

Exercise: a potential contributing factor to the relationship between folate and dementia.

Middleton LE, Kirkland SA, Maxwell CJ, Hogan DB, Rockwood K.

J Am Geriatr Soc. 2007 Jul;55(7):1095-8.

PMID:
17608885
5.

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA.

Neuron. 2007 Jun 7;54(5):713-20.

6.

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L.

Science. 2007 May 4;316(5825):750-4.

7.

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

ADAPT Research Group., Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M.

Neurology. 2007 May 22;68(21):1800-8. Epub 2007 Apr 25.

PMID:
17460158
8.

Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.

Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM Jr, Olin JT, Regier D, Sano M, Mintzer JE.

Int Psychogeriatr. 2007 Jun;19(3):539-58. Epub 2007 Apr 23. Review.

PMID:
17451614
9.

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH.

Arch Neurol. 2007 Mar;64(3):431-4.

PMID:
17353389
10.

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, Waldemar G, Minthon L, Blennow K.

Arch Neurol. 2007 Mar;64(3):366-70.

PMID:
17353378
11.

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P.

Nat Genet. 2007 Feb;39(2):168-77. Epub 2007 Jan 14.

12.

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE.

Nat Genet. 2007 Jan;39(1):17-23.

PMID:
17192785
13.

PET of brain amyloid and tau in mild cognitive impairment.

Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

N Engl J Med. 2006 Dec 21;355(25):2652-63.

14.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6.

PMID:
17132964
15.

APOE distribution in world populations with new data from India and the UK.

Singh PP, Singh M, Mastana SS.

Ann Hum Biol. 2006 May-Jun;33(3):279-308.

PMID:
17092867
16.

Fruit and vegetable juices and Alzheimer's disease: the Kame Project.

Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB.

Am J Med. 2006 Sep;119(9):751-9.

17.

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.

Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J.

Lancet Neurol. 2006 Sep;5(9):735-41.

PMID:
16914401
18.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
19.

Family history of dementia in early-onset versus very late-onset Alzheimer's disease.

McMurtray AM, Ringman J, Chao SZ, Licht E, Saul RE, Mendez MF.

Int J Geriatr Psychiatry. 2006 Jun;21(6):597-8. No abstract available.

PMID:
16783800
20.

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA.

J Neurosci. 2006 May 31;26(22):6069-76.

Supplemental Content

Support Center